The USA's health care spending will almost double to $4,100.0 billion by 2016 and about 20% of the total economy, according to a report published by the National Health Statistics Group at the Centers for Medicare and Medicaid Services (CMS). Per capita health spending from both private and public sources would reach $12,782, from just under $7,500 in 2006. The shift of prescription drug costs towards Medicare and other public programs "lacks a long-term financial stability," and could be a source of future problems.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze